Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders.
The aim of this study is to review data for several promising novel pharmacological drugs for anxiety disorders and describe how they exert their effects. We presented a review of the published literature. Online search plus reference list checking was also used. The neurobiology of anxiety is overviewed. N-methyl-D-aspartate and beta adrenaline are involved in memory consolidation. We describe studies using memantine, D-cycloserine, propranolol, and riluzole that modulate these pathways. There are a number of promising new therapies, but these require further studies before they can enter routine clinical practice.